Authors: KING DJ WAGER E

Citation: Dj. King et E. Wager, HEMATOLOGICAL SAFETY OF ANTIPSYCHOTIC-DRUGS, J PSYCHOPH, 12(3), 1998, pp. 283-288

Authors: WAGER E

Citation: E. Wager, GHOSTWRITING, Lancet, 351(9117), 1998, pp. 1741-1741

Authors: HEADING RC WAGER E TOOLEY PJH

Citation: Rc. Heading et al., RELIABILITY OF SYMPTOM ASSESSMENT IN DYSPEPSIA, European journal of gastroenterology & hepatology, 9(8), 1997, pp. 779-781

Authors: WAGER E TOOLEY PJH PEARCE GL WILTON LV MANN RD

Citation: E. Wager et al., A COMPARISON OF 2 COHORT STUDIES EVALUATING THE SAFETY OF CISAPRIDE -PRESCRIPTION-EVENT MONITORING AND A LARGE PHASE-IV STUDY, European Journal of Clinical Pharmacology, 52(2), 1997, pp. 87-94

Authors: WAGER E

Citation: E. Wager, REDEFINING AUTHORSHIP - DRUG-INDUSTRY IS INCREASINGLY ALLOWING EMPLOYEES TO BE NAMED AS AUTHORS, BMJ. British medical journal, 312(7043), 1996, pp. 1423-1423

Authors: WAGER E TOOLEY PJH EMANUEL MB WOOD SF

Citation: E. Wager et al., GET PATIENTS CONSENT TO ENTER CLINICAL-TRIALS, BMJ. British medical journal, 311(7007), 1995, pp. 734-737